Trigemina
Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.
Business Model:
Revenue: $1M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Trigemina Information
Geographic Data
Address: -
City: San Francisco
State: CA
Zip: -
Country: US
Financial Info
Stage:
series a
Raised Last:
$2M
Raised Total:$28M
Social
Metrics
7,841,056Website Global Rank
500Website Monthly Traffic
Twitter Followers
Description
Trigemina, Inc. develops non-opiate drug formulations and delivery systems for the pain therapy. The company’s products include TI-001, an intranasal oxytocin that targets chronic and sub-acute head pain; and TI-002, a non-opioid treatment that addresses a range of pain, including neuropathic pain throughout the body. Its drugs are delivered via the nasal-cerebral pathway. The company was founded in 2006 and is based in Mountain View, California.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
